ES2723598T3 - Composition for the prevention or treatment of ovarian polycystosis and its related symptoms - Google Patents

Composition for the prevention or treatment of ovarian polycystosis and its related symptoms Download PDF

Info

Publication number
ES2723598T3
ES2723598T3 ES16197205T ES16197205T ES2723598T3 ES 2723598 T3 ES2723598 T3 ES 2723598T3 ES 16197205 T ES16197205 T ES 16197205T ES 16197205 T ES16197205 T ES 16197205T ES 2723598 T3 ES2723598 T3 ES 2723598T3
Authority
ES
Spain
Prior art keywords
prevention
treatment
composition
related symptoms
polycystosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16197205T
Other languages
Spanish (es)
Inventor
Giovanni Scapagnini
Marco Roberto Maria Antonio Di
Katia Mangano
Sormani Sonia Longo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Claride Pharma Srl
Original Assignee
Claride Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claride Pharma Srl filed Critical Claride Pharma Srl
Application granted granted Critical
Publication of ES2723598T3 publication Critical patent/ES2723598T3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

Composición que comprende i) ácido corosólico, elagitaninos y/o un extracto de Banaba (Lagerstroemia speciosa), ii) inositol y/o sus sales y/o formas isómeras, iii) Ipomoea Batatas y un vehículo fisiológicamente aceptable, para uso en la prevención y/o tratamiento del síndrome de ovario poliquístico.Composition comprising i) corosolic acid, elagitannins and / or an extract of Banaba (Lagerstroemia speciosa), ii) inositol and / or its salts and / or isomeric forms, iii) Ipomoea Batatas and a physiologically acceptable vehicle, for use in prevention and / or treatment of polycystic ovary syndrome.

ES16197205T 2015-11-05 2016-11-04 Composition for the prevention or treatment of ovarian polycystosis and its related symptoms Active ES2723598T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A005087A ITUB20155087A1 (en) 2015-11-05 2015-11-05 COMPOSITION TO PREVENT OR TREAT THE POLYCHISTIC OVAR SYNDROME AND RELATED SYMPTOMS

Publications (1)

Publication Number Publication Date
ES2723598T3 true ES2723598T3 (en) 2019-08-29

Family

ID=55410033

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16197205T Active ES2723598T3 (en) 2015-11-05 2016-11-04 Composition for the prevention or treatment of ovarian polycystosis and its related symptoms

Country Status (12)

Country Link
EP (1) EP3165229B8 (en)
DK (1) DK3165229T3 (en)
ES (1) ES2723598T3 (en)
HR (1) HRP20190676T1 (en)
HU (1) HUE043246T2 (en)
IT (1) ITUB20155087A1 (en)
LT (1) LT3165229T (en)
PL (1) PL3165229T3 (en)
PT (1) PT3165229T (en)
RS (1) RS58661B1 (en)
SI (1) SI3165229T1 (en)
TR (1) TR201906364T4 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20163025A1 (en) * 2016-04-29 2017-10-29 Sochim Int S P A COMPOSITION FOR THE TREATMENT OF THE POLICISTIC OVARIAN SYNDROME
CN117164686B (en) * 2022-05-11 2024-05-31 中国农业大学 Stress-resistance related protein IbRCD1, related biological material and application thereof
CN115282176A (en) * 2022-08-24 2022-11-04 北京彩晔健康管理有限公司 Composition for delaying ovarian aging and improving polycystic ovarian syndrome and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1841440A2 (en) * 2004-12-22 2007-10-10 Renaissance Herbs, Inc. Pharmaceutical, therapeutic, and dietary compositions derived from lagerstroemia speciosa l. plant
US8349373B1 (en) * 2011-07-25 2013-01-08 Conrad Anton Smith Dietary supplement for use in a weight loss program
CN102631516A (en) * 2012-05-02 2012-08-15 马守云 Medicament for treating infertility

Also Published As

Publication number Publication date
SI3165229T1 (en) 2019-06-28
PT3165229T (en) 2019-05-28
RS58661B1 (en) 2019-06-28
DK3165229T3 (en) 2019-05-13
PL3165229T3 (en) 2019-08-30
HRP20190676T1 (en) 2019-05-31
HUE043246T2 (en) 2019-08-28
EP3165229B1 (en) 2019-02-13
TR201906364T4 (en) 2019-05-21
ITUB20155087A1 (en) 2017-05-05
EP3165229A1 (en) 2017-05-10
LT3165229T (en) 2019-05-27
EP3165229B8 (en) 2019-05-22

Similar Documents

Publication Publication Date Title
CO2017005626A2 (en) A composition comprising bacteroides thetaiotaomicron
CL2018003754A1 (en) Glucagon derivative, conjugate thereof, composition comprising the same and therapeutic use thereof.
CL2020002269A1 (en) Fold-Binding Antibody33; polynucleotide; vector; host cell; method of producing the antibody; pharmaceutical composition; combination product; use of the antibody to treat an inflammatory condition (divisional application no. 201702433)
CL2018001790A1 (en) Processes to prepare a jak1 inhibitor and new forms of this (divisional application 201602748)
CL2017003459A1 (en) Cyclic sulfamoylarylamide derivatives and their use as medicines for the treatment of hepatitis b.
ECSP19015192A (en) COMPOSITIONS AND METHODS OF INHIBITING MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS
MY195681A (en) Aqueous Pharmaceutical Formulation Comprising Anti-Pd-L1 Antibody Avelumab
UY35984A (en) NEW SALTS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME FOR THE TREATMENT OF INFLAMMATORY DISORDERS.
CL2016003422A1 (en) Lysine specific demethylase-1 inhibitors
ES2871036T3 (en) Method for treating bile acid-related disorders
CL2020000632A1 (en) Composition and method for the treatment of autism.
CR20170219A (en) BROMODOMINUM INHIBITORS
CL2016001587A1 (en) Derivative based on 1,2-naphthoquinone and method of preparation thereof.
CO2019008103A2 (en) Pharmaceutical compositions for combination therapy
SV2017005412A (en) COMPOUNDS OF 1-RENT-6-OXO-1,6-DIHIDROPIRIDIN-3-ILO AND USES OF THE SAME
CL2017001904A1 (en) Composition for the treatment of hepatic veno-occlusive disease.
CO2018013020A2 (en) Pharmaceutical combinations for cancer treatment
AR102790A1 (en) ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS TO TREAT FOOD AND SURFACE PRODUCTS
CL2016002754A1 (en) Treatment device and treatment procedure for pickling and phosphating metal parts
ES2723598T3 (en) Composition for the prevention or treatment of ovarian polycystosis and its related symptoms
MX366499B (en) Liquid pharmaceutical composition.
CL2017000563A1 (en) Use of elsiglutide to treat gastrointestinal mucositis that includes chemotherapy-induced diarrhea.
DOP2017000085A (en) STABILIZED DERIVATIVES OF ADRENOMEDULINE AND USE OF THE SAME
CL2021000930A1 (en) Novel Pyridazines
DOP2017000065A (en) FORMULATION THAT INCLUDES GLICOPIRROLATE, METHOD AND APPLIANCE